Notice: This company has been marked as potentially delisted and may not be actively trading.

(ANTX) (ANTX) Stock Forecast & Price Target

(ANTX) - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 5 Analyst Ratings

Based on 5 Wall Street analysts who have issued ratings for (ANTX) in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 1 has given a sell rating, 3 have given a hold rating, and 1 has given a buy rating for ANTX.

Consensus Price Target

$2.00
88.68% Upside

High Forecast	$3.00
Average Forecast	$2.00
Low Forecast	$1.00

According to the 5 analysts' twelve-month price targets for (ANTX), the average price target is $2.00. The highest price target for ANTX is $3.00, while the lowest price target for ANTX is $1.00. The average price target represents a forecasted upside of 88.68% from the current price of $1.06.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Hold	Hold	Hold	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$2.00	$2.00	$5.00	$24.50
Forecasted Upside	88.68% Upside	-22.06% Downside	34.77% Upside	100.00% Upside

Biden's Executive Order, Dems Digital Money Legislation, First Step To (Ad)

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

ANTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ANTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

(ANTX) Stock vs. The Competition

Type	(ANTX)	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.77	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	88.68% Upside	1,005.12% Upside	7.87% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/9/2024	Leerink Partnrs 0 of 5 stars	J. Schwartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/9/2024	Evercore ISI 2 of 5 stars	L. Bayko Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	In-Line ➝ Underperform
8/9/2024	JMP Securities 2 of 5 stars		Lower Target	Market Outperform ➝ Market Outperform	$6.00 ➝ $3.00	+13.64%
8/9/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform	$5.00 ➝ $1.00	-62.12%
4/1/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Perform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:23 AM ET.

ANTX Forecast - Frequently Asked Questions

What is (ANTX)'s forecast for 2024?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for (ANTX) is $2.00, with a high forecast of $3.00 and a low forecast of $1.00.
Should I buy or sell (ANTX) stock right now?: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for (ANTX) in the last year. There is currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ANTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ANTX, but not buy additional shares or sell existing shares.
Does (ANTX)'s stock price have much downside?: According to analysts, (ANTX)'s stock has a predicted downside of -22.06% based on their 12-month stock forecasts.
Has (ANTX) been upgraded or downgraded by Wall Street analysts recently?: Over the previous 90 days, (ANTX)'s stock had 3 downgrades and 2 upgrades by analysts.
What analysts cover (ANTX)?: (ANTX) has been rated by research analysts at Evercore ISI, JMP Securities, Leerink Partners, and Leerink Partnrs in the past 90 days.
Do Wall Street analysts like (ANTX) more than its competitors?: Analysts like (ANTX) less than other "medical" companies. The consensus rating for (ANTX) is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ANTX compares to other companies.